Japan's JIC plans to sell JSR to Mitsui Chemicals in over $8.2b deal

Deloitte launched Edisyl, an AI company formed from Flipside Crypto’s AI business acquisition, adding 24 employees. BlueMatrix completed its acquisition of Aiera, an AI financial research platform. Mitsui Chemicals agreed to acquire JSR for ¥1.84 trillion ($11.6 billion), strengthening its semiconductor materials position.

iORGANBIO, a life sciences startup, received a strategic investment from Mitsui Chemicals (TSE: 4183) and will collaborate to combine AI with high-oxygen-permeability cell culture plates. The partnership aims to address organoid reproducibility, a critical issue in drug testing, as the FDA ends animal testing requirements. iORGANBIO's CellForge™ platform uses AI and robotics to guide cell differentiation, while Mitsui's plates improve oxygen supply to 3D cell cultures.

Mitsui Chemicals announced plans to acquire JSR, a semiconductor materials maker, for approximately $11.6 billion (JPY1.84 trillion). The deal aims to expand Mitsui's presence in the semiconductor materials sector. According to the companies, the acquisition will strengthen their combined position in the growing semiconductor market.

Mitsui Chemicals agreed to buy JSR from JIC for $9B, including $2.9B in debt. This is Japan's largest chemical industry acquisition. Mitsui plans to focus on semiconductor materials, shifting from diversified chemicals.

Mitsui Chemicals plans to acquire JSR Corporation for $8.81 billion, expanding its semiconductor materials business. The deal, expected to close in 2027, aims to boost ICT profits to $1.20 billion by 2030 and includes $253 million in annual profit improvements by 2035. JSR's semiconductor materials business generated $1.24 billion in 2025 sales. Mitsui will finance the acquisition with debt and equity, targeting reduced debt ratios post-transaction.

Mitsui Chemicals will acquire JSR from Japan Investment Corp. for $11.6B. JSR, a Tokyo-based semiconductor materials company, will become a subsidiary. In 2025, JSR reported a net profit of $384.1M on sales of $2.94B, recovering from a 2024 loss.